MedX Health Corp (MDX.V)
| Previous Close | 0.0900 |
| Open | 0.0800 |
| Bid | 0.0800 x 0 |
| Ask | 0.0850 x 0 |
| Day's Range | 0.0800 - 0.0900 |
| 52 Week Range | 0.0300 - 0.1100 |
| Volume | |
| Avg. Volume | 178,762 |
| Market Cap | 23.576M |
| Beta (5Y Monthly) | 1.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | May 02, 2024 - May 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.MedX Health Full Year 2023 Earnings: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022)
MedX Health ( CVE:MDX ) Full Year 2023 Results Key Financial Results Revenue: CA$456.1k (down 11% from FY 2022). Net...
Business WireMedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,000,000 and Provides an Update on Amendment to Series I Convertible Notes
MISSISSAUGA, Ontario, May 01, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit ("Unit"). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Commo
Business WireMedX Health and Health Partners announce the successful results of its pilot project in the United Kingdom and move towards a partnership agreement
MISSISSAUGA, Ontario, February 28, 2024--MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce they have successfully completed the pilot project with Health Partners. MedX and Health Partners are working together to begin the roll-out of this service to targeted clients engaged in a preventative approach to health care management.
